Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
ADC Therapeutics
ADC Therapeutics
(ADCT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zynlonta
Loncastuximab tesirine
2021-04-23
B-cell lymphoma
,
Large b-cell lymphoma diffuse
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Loncastuximab tesirine
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
burkitt lymphoma
,
follicular lymphoma
,
mantle-cell lymphoma
,
non-hodgkin lymphoma
,
waldenstrom macroglobulinemia
,
large b-cell lymphoma diffuse
Epratuzumab
precursor cell lymphoblastic leukemia-lymphoma
,
philadelphia chromosome
Calcium dobesilate
waldenstrom macroglobulinemia
CAMIDANLUMAB
renal cell carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
urinary bladder neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
hodgkin disease
,
myelodysplastic syndromes
CAMIDANLUMAB TESIRINE
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
fallopian tube neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
breast neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
hodgkin disease
,
myelodysplastic syndromes
Loncastuximab
non-hodgkin lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
burkitt lymphoma
,
follicular lymphoma
,
mantle-cell lymphoma
,
waldenstrom macroglobulinemia
,
large b-cell lymphoma diffuse
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use